What to watch: Marksans Pharma - Goa units get USFDA nod

Marksans Pharma on Thursday said it has received Establishment Inspection Report from the US FDA for its Goa facility. The inspection was carried out from February 25 to March 6. The company is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets. Marksans’ manufacturing facilities are approved by regulatory agencies including UK MHRA, US FDA and Australia TGA.